American Society of Hirudotherapy

Investigation of oxidant-antioxidant status in patients treated with hirudotherapy: an experimental study

Research article published in JPMA. The Journal of the Pakistan Medical Association (2024)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportClinical TrialsDrug DevelopmentSarikan I, Savas H · JPMA. The Journal of the Pakistan Medical Association, 2024

Abstract

OBJECTIVES: To examine the influence of hirudotherapy on parameters of oxidative stress. METHODS: The cross-sectional study was conducted from March 29 to September 29, 2021, at the Alanya Research and Training Hospital's Traditional and Complementary Medicine Application Centre, Turkey, and comprised adult volunteers of either gender. The participants were subjected to two sessions of hirudotherapy 4 weeks apart. Total antioxidant status, total oxidant status, oxidative stress index values, ischaemia-modified albumin level, paraoxonase 1, disulfide, native thiol, total thiol, and arylesterase levels were assessed at baseline and after the second hirudotherapy session. Data was analysed using SPSS 15. RESULTS: Of the 50 subjects, 30(60%) were females and 20(40%) were males. The overall mean age was 47.10±15.16 years. Oxidative stress, ischaemia-modified albumin and disulfide levels decreased, but not significantly (p>0.05). The reduction in disulfide levels was significant (p=0.021). CONCLUSIONS: Hirudotherapy, within its limitations, could reduce oxidative stress.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsHumansFemaleMaleOxidative StressAdultAntioxidantsAryldialkylphosphataseCross-Sectional StudiesMiddle AgedSerum Albumin, HumanCarboxylic Ester HydrolasesDisulfides

Summary

To examine the influence of hirudotherapy on parameters of oxidative stress. The cross-sectional study was conducted from March 29 to September 29, 2021, at the Alanya Research and Training Hospital's Traditional and Complementary Medicine Application Centre, Turkey, and comprised adult volunteers of either gender.

Why This Matters for Hirudotherapy

This cross-sectional study directly examined the influence of hirudotherapy on oxidative stress parameters in 50 adult volunteers who underwent two leech therapy sessions four weeks apart at a Turkish Traditional and Complementary Medicine center. Investigators measured total antioxidant status, total oxidant status, oxidative stress index, ischaemia-modified albumin, paraoxonase 1, disulfide, native/total thiol, and arylesterase levels at baseline and after the second session. For ASH's domain, this work offers preliminary human biochemical data suggesting that leech therapy may modulate systemic redox balance—particularly disulfide levels, which showed a significant reduction (p=0.021)—hinting at potential antioxidant mechanisms beyond the well-characterized anticoagulant actions of leech salivary components. However, caution is warranted: most measured oxidative stress markers decreased only non-significantly, the study involved just two sessions with no long-term follow-up reported, and the cross-sectional design with 50 participants provides exploratory rather than confirmatory evidence. The absence of detailed outcome data beyond group-level p-values further limits mechanistic conclusions.

Citation

Investigation of oxidant-antioxidant status in patients treated with hirudotherapy: an experimental study.

Sarikan I, Savas H · JPMA. The Journal of the Pakistan Medical Association, 2024

Added to ASH library: March 18, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.